NMPA Approval

Erlotinib Hydrochloride Tablets

Approval Number

国药准字H20249793

Company

广州科锐特药业有限公司

Registration Date

December 25, 2024

Drug Information

Generic Name

盐酸厄洛替尼片

Dosage Form

片剂

Strength

150mg（按C₂₂H₂₃N₃O₄计）

Drug Type

化学药品

Registration Date

December 25, 2024

Company Information

Applicant Company

Company Name

广州科锐特药业有限公司

Company Address

广州市黄埔区春分路80号

Manufacturing Company

Company Name

广州科锐特药业有限公司

Company Address

广州市黄埔区春分路80号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸厄洛替尼片 - NMPA 批准文号 | MedPath